Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: A twelve-month follow-up

References

• Bernklev T, Jahnsen J, Aadland E, Sauar J, Schulz T, Lygren I, et al. and the IBSEN Study Group. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol 2004; 39: 365–73
   PubMed Web of Science ®Google Scholar
• van der Eijk I, Vlachonikolis IG, Munkholm P, Nijman J, Bernklev T, Politi P, et al. and the EC-IBD Study Group. The role of quality of care in health-related quality of life in patients with IBD. Inflamm Bowel Dis 2004; 10: 392–8
   PubMed Web of Science ®Google Scholar
• Janke KH, Klump B, Gregor M, Meisner C, Haeuser W. Determinants of life satisfaction in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 272–86
   PubMed Web of Science ®Google Scholar
• Saibeni S, Cortinovis I, Beretta L, Tatarella M, Ferraris L, Rondonotti E, et al. and the Gruppo di Studio per le Malattie Infiammatorie Intestinali. Gender and disease activity influence health-related quality of life in inflammatory bowel diseases. Hepatogastroenterology 2005; 52: 509–15
   PubMedGoogle Scholar
• Mussell M, Baecker U, Nagel N, Singer MV. Predictors of disease-related concerns and other aspects of health-related quality of life in outpatients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2004; 16: 1273–80
   PubMedGoogle Scholar
• Leong RW, Lawrance IC, Ching JY, Cheung CM, Fung SS, Ho JN, et al. Knowledge, quality of life, and use of complementary and alternative medicine and therapies in inflammatory bowel disease: a comparison of Chinese and Caucasian patients. Dig Dis Sci 2004; 49: 1672–6
   PubMed Web of Science ®Google Scholar
• Levenstein S, Li Z, Almer S, Barbosa A, Marquis P, Moser G, et al. Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease. Am J Gastroenterol 2001; 96: 1822–30
   PubMed Web of Science ®Google Scholar
• van der Zaag-Loonen H, Grootenhuis MA, Last BF, Derkx HH. Coping strategies and quality of life of adolescents with inflammatory bowel disease. Qual Life Res 2004; 13: 1011–9
   PubMed Web of Science ®Google Scholar
• Levenstein S, Prantera C, Varvo V, Scribano ML, Andreoli A, Luzi C, et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 2000; 95: 1213–20
   PubMed Web of Science ®Google Scholar
• Kennedy AP, Nelson E, Reeves D, Richardson G, Roberts C, Robinson A, et al. A randomised controlled trial to assess the effectiveness and cost of a patient-orientated self-management approach to chronic inflammatory bowel disease. Gut 2004; 53: 1639–45
   PubMed Web of Science ®Google Scholar
• Waters BM, Jensen L, Fedorak RN. Effects of formal education for patients with inflammatory bowel disease: a randomized controlled trial. Can J Gastroenterol 2005; 19: 235–44
   PubMed Web of Science ®Google Scholar
• Mittermaier C, Dejaco C, Waldhoer T, Oefferlbauer-Ernst A, Miehsler W, Beier M, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 2004; 66: 79–84
   PubMed Web of Science ®Google Scholar
• Levenstein S, Prantera C, Varvo V, Scribano ML, Berto E, Andreoli A, et al. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol 1994; 89: 1219–25
   PubMed Web of Science ®Google Scholar
• Bitton A, Sewitch MJ, Peppercorn MA, deB Edwardes MD, Shah S, Ransil B, et al. Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study. Am J Gastroenterol 2003; 98: 2203–8
   PubMed Web of Science ®Google Scholar
• Greene BR, Blanchard EB, Wan CK. Long-term monitoring of psychosocial stress and symptomatology in inflammatory bowel disease. Behav Res Ther 1994; 32: 217–26
   PubMed Web of Science ®Google Scholar
• Garrett VD, Brantley PJ, Jones GN, McKnight GT. The relation between daily stress and Crohn's disease. J Behav Med 1991; 14: 87–96
   PubMed Web of Science ®Google Scholar
• Larsson K, Sundberg Hjelm M, Karlbom U, Nordin K, Anderberg UM, Lööf L. A group-based patient education programme for high-anxiety patients with Crohn disease or ulcerative colitis. Scand J Gastroenterol 2003; 38: 763–9
   PubMed Web of Science ®Google Scholar
• Keller W, Pritsch M, von Wietersheim J, Scheib P, Osborn W, Balck F, et al. and the German Study Group on Psychosocial Intervention in Crohn's Disease. Effect of psychotherapy and relaxation on the psychosocial and somatic course of Crohn's disease: main results of the German prospective multicenter psychotherapy treatment study on Crohn's disease. J Psychosom Res 2004; 56: 687–96
   PubMed Web of Science ®Google Scholar
• Jantschek G, Zeitz M, Pritsch M, Wirsching M, Klor HU, Studt HH, et al. Effect of psychotherapy on the course of Crohn's disease. Results of the German prospective multicenter psychotherapy treatment study on Crohn's disease. German Study Group on Psychosocial Intervention in Crohn's Disease. Scand J Gastroenterol 1998; 33: 1289–96
   PubMed Web of Science ®Google Scholar
• Maunder RG, Esplen MJ. Supportive-expressive group psychotherapy for persons with inflammatory bowel disease. Can J Psychiatry 2001; 46: 622–6
   PubMed Web of Science ®Google Scholar
• Smith GD, Watson R, Roger D, McRorie E, Hurst N, Luman W, et al. Impact of a nurse-led counselling service on quality of life in patients with inflammatory bowel disease. J Adv Nurs 2002; 38: 152–60
   PubMed Web of Science ®Google Scholar
• Milne B, Joachim G, Niedhardt J. A stress management programme for inflammatory bowel disease patients. J Adv Nurs 1986; 11: 561–7
   PubMed Web of Science ®Google Scholar
• Shaw L, Ehrlich A. Relaxation training as a treatment for chronic pain caused by ulcerative colitis. Pain 1987; 29: 287–93
   PubMed Web of Science ®Google Scholar
• Schwarz SP, Blanchard EB. Evaluation of a psychological treatment for inflammatory bowel disease. Behav Res Ther 1991; 29: 167–77
   PubMed Web of Science ®Google Scholar
• Borgaonkar MR, Townson G, Donnelly M, Irvine EJ. Providing disease-related information worsens health-related quality of life in inflammatory bowel disease. Inflamm Bowel Dis 2002; 8: 264–9
   PubMed Web of Science ®Google Scholar
• Bregenzer N, Lange A, Fürst A, Gross V, Schölmerich J, Andus T. Patient education in inflammatory bowel disease does not influence patients’ knowledge and long-term psychosocial well-being. Z Gastroenterol 2005; 43: 367–71
   PubMed Web of Science ®Google Scholar
• Elsenbruch S, Langhorst J, Popkirowa K, Müller T, Luedtke R, Franken U, et al. Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychother Psychosom 2005; 74: 277–87
   PubMed Web of Science ®Google Scholar
• Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955;1041–8.
   Google Scholar
• Michalsen A, Grossman P, Lehmann N, Knoblauch NT, Paul A, Moebus S, et al. Psychological and quality-of-life outcomes from a comprehensive stress reduction and lifestyle program in patients with coronary artery disease: results of a randomized trial. Psychother Psychosom 2005; 74: 344–52
   PubMed Web of Science ®Google Scholar
• Hoffmann JC, Zeitz M, Bischoff SC, Brambs HJ, Bruch HP, Buhr HJ, et al. Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German Society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease. Z Gastroenterol 2004; 42: 979–83
   PubMed Web of Science ®Google Scholar
• Benson H, Stuart M. The wellness book. Mind-body medicine. Fireside, New York 1999
   Google Scholar
• Kabatt-Zinn J. Full catastrophe living: using the wisdom of your body and mind to face stress, pain, and illness. Delacorte, New York 1990
   Google Scholar
• Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Br Med J 1989; 298: 82–6
   PubMed Web of Science ®Google Scholar
• Bullinger M. German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA project. International quality of life assessment. Soc Sci Med 1995; 41: 1359–66
   PubMed Web of Science ®Google Scholar
• Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–83
   PubMed Web of Science ®Google Scholar
• McHorney CA, Ware JE, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 32: 40–66
   PubMed Web of Science ®Google Scholar
• McHorney CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247–63
   PubMed Web of Science ®Google Scholar
• Bullinger M, Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand. Hogrefe-Verlag, Göttingen 1998
   Google Scholar
• Hauser W, Dietz N, Grandt D, Steder-Neukamm U, Janke KH, Stein U, et al. Validation of the inflammatory bowel disease questionnaire IBDQ-D, German version, for patients with ileal pouch anal anastomosis for ulcerative colitis. Z Gastroenterol 2004; 42: 131–9
   PubMedGoogle Scholar
• Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology 1994; 106: 287–96
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology 2004; 126: 402–13
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Löfberg R, Modigliani R, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002; 122: 512–30
   PubMed Web of Science ®Google Scholar
• Franke GH. Brief symptom inventory von LR Derogatis (Kurzform der SCL-90-R), German version. Beltz Test, Göttingen 2000
   Google Scholar
• Derogatis LR, Spencer PM. The Brief Symptom Inventory (BSI): administration, scoring and procedures manual-I. Clin Psychometric Res, Towson 1982
   Google Scholar
• Schmitz N, Hartkamp N, Kiuse J, Franke GH, Reister G, Tress W. The symptom check-list-90-R (SCL-90-R): a German validation study. Qual Life Res 2000; 9: 185–93
   PubMed Web of Science ®Google Scholar
• Maunder RG, de Rooy EC, Toner BB, Greenberg GR, Steinhart AH, McLeod RS, et al. Health-related concerns of people who receive psychological support for inflammatory bowel disease. Can J Gastroenterol 1997; 11: 681–5
   PubMedGoogle Scholar
• Mayer EA. Psychological stress and colitis. Gut 2000; 46: 595–6
   PubMed Web of Science ®Google Scholar
• Demaude J, Salvador-Cartier C, Fioramonti J, Ferrier L, Bueno L. Phenotypic changes in colonocyte following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction. Gut 2006; 55: 655–61
   PubMed Web of Science ®Google Scholar
• Farhadi A, Keshavarzian A, Van de Kar LD, Jakate S, Domm A, Zhang L, et al. Heightened responses to stressors in patients with inflammatory bowel disease. Am J Gastroenterol 2005; 100: 1796–804
   PubMed Web of Science ®Google Scholar
• Langhorst J, Anthonisen IB, Steder-Neukamm U, Lüdtke R, Spahn G, Michalsen A, et al. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in German patients with inflammatory bowel disease: results from a national survey. Inflamm Bowel Dis 2005; 11: 287–95
   PubMed Web of Science ®Google Scholar